Stringent patentability requirements present a challenge to obtaining broad-based antibody claims, so companies should develop a strategy based on multiple reinforcing layers of protection.
Jane E. Remillard
Advertisement
Jane E. Remillard is the leader of the Life Sciences Intellectual Property Team at Nelson Mullins, [email protected]
Articles by Jane E. Remillard
Advertisement
Latest Updated Articles
Patentability Considerations for Antibody-Related InventionsAugust 13th 2020
Advertisement
Advertisement